Table 1.
Demographic and clinical parameters of CD patients.
| Parameter | Patients | Controls |
|---|---|---|
| No. | 21 | 20 |
| Age | 6-17 | 6-17 |
| Sexa | 15 : 5 | 14 : 6 |
| Ethnicity | French Caucasian | French Caucasian |
| Disease activity | 9 newly diagnosed | — |
| 6 relapsed | — | |
| 6 in remission | — | |
| Drugs | 15 none | — |
| 6 under treatment | — |
aMale : female ratio. The newly diagnosed patients had not received any treatment. The relapsed patients were previously treated with azathioprine, prednisone, anakinra, and natalizumab in different combinations. However, they were currently not receiving any treatment. The patients in remission were currently receiving TNF-α blocking antibodies (infliximab or adalimumab), prednisone, or azathioprine.